Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014

[PR Newswire] – THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Nov. 6, 2014 /PRNewswire/ — Amgen (AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that more than 50 abstracts from the . . . → Read More: Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014 Similar Articles: Company Update (NYSE:LLY): Type 2 diabetes: Jentadueto® (linagliptin and metformin hydrochloride) tablets label updated to include new data on blood glucose reductions in treatment-naive adults with high baseline A1C Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Webcast of 2014 Second Quarter Financial Results Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio